Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
Chemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate altern...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/full |
_version_ | 1811332773603966976 |
---|---|
author | Vincent Duval Paul Alayrac Jean-Sébastien Silvestre Angélique Levoye Angélique Levoye |
author_facet | Vincent Duval Paul Alayrac Jean-Sébastien Silvestre Angélique Levoye Angélique Levoye |
author_sort | Vincent Duval |
collection | DOAJ |
description | Chemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate alternative signaling pathways has changed the paradigm regarding chemokine-related functions. Among these ACKRs, several studies have highlighted the exclusive role of ACKR3, previously known as C-X-C chemokine receptor type 7 (CXCR7), in CVD. Indeed, ACKR3 exert atheroprotective, cardioprotective and anti-thrombotic effects through a wide range of cells including endothelial cells, platelets, inflammatory cells, fibroblasts, vascular smooth muscle cells and cardiomyocytes. ACKR3 functions as a scavenger receptor notably for the pleiotropic chemokine CXCL12, but also as a activator of different pathways such as β-arrestin-mediated signaling or modulator of CXCR4 signaling through the formation of ACKR3-CXCR4 heterodimers. Hence, a better understanding of the precise roles of ACKR3 may pave the way towards the development of novel and improved therapeutic strategies for CVD. Here, we summarize the structural determinant characteristic of ACKR3, the molecules targeting this receptor and signaling pathways modulated by ACKR3. Finally, we present and discuss recent findings regarding the role of ACKR3 in CVD. |
first_indexed | 2024-04-13T16:42:02Z |
format | Article |
id | doaj.art-7ea10500dcaf4f0b8f8f1132b06092a8 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-04-13T16:42:02Z |
publishDate | 2022-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-7ea10500dcaf4f0b8f8f1132b06092a82022-12-22T02:39:12ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.906586906586Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular DiseasesVincent Duval0Paul Alayrac1Jean-Sébastien Silvestre2Angélique Levoye3Angélique Levoye4Université Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUFR Santé Médecine Biologie Humaine, Université Sorbonne Paris Nord, Bobigny, FranceChemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate alternative signaling pathways has changed the paradigm regarding chemokine-related functions. Among these ACKRs, several studies have highlighted the exclusive role of ACKR3, previously known as C-X-C chemokine receptor type 7 (CXCR7), in CVD. Indeed, ACKR3 exert atheroprotective, cardioprotective and anti-thrombotic effects through a wide range of cells including endothelial cells, platelets, inflammatory cells, fibroblasts, vascular smooth muscle cells and cardiomyocytes. ACKR3 functions as a scavenger receptor notably for the pleiotropic chemokine CXCL12, but also as a activator of different pathways such as β-arrestin-mediated signaling or modulator of CXCR4 signaling through the formation of ACKR3-CXCR4 heterodimers. Hence, a better understanding of the precise roles of ACKR3 may pave the way towards the development of novel and improved therapeutic strategies for CVD. Here, we summarize the structural determinant characteristic of ACKR3, the molecules targeting this receptor and signaling pathways modulated by ACKR3. Finally, we present and discuss recent findings regarding the role of ACKR3 in CVD.https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/fullatypical chemokine receptorsACKR3chemokinecardiovascular diseasessignalling |
spellingShingle | Vincent Duval Paul Alayrac Jean-Sébastien Silvestre Angélique Levoye Angélique Levoye Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases Frontiers in Endocrinology atypical chemokine receptors ACKR3 chemokine cardiovascular diseases signalling |
title | Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases |
title_full | Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases |
title_fullStr | Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases |
title_full_unstemmed | Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases |
title_short | Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases |
title_sort | emerging roles of the atypical chemokine receptor 3 ackr3 in cardiovascular diseases |
topic | atypical chemokine receptors ACKR3 chemokine cardiovascular diseases signalling |
url | https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/full |
work_keys_str_mv | AT vincentduval emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases AT paulalayrac emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases AT jeansebastiensilvestre emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases AT angeliquelevoye emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases AT angeliquelevoye emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases |